TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
68.94
+0.09 (0.12%)
At close: May 22, 2026, 4:00 PM EDT
68.46
-0.48 (-0.69%)
After-hours: May 22, 2026, 7:57 PM EDT
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $2.38 billion as of May 22, 2026. Its market cap has decreased by -24.45% in one year.
Market Cap
2.38B
Enterprise Value
2.78B
1-Year Change
-24.45%
Ranking
Category
Stock Price
$68.94
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $2.38B, an increase of 426.53%. That is a compound annual growth rate of 26.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 2.38B | -42.69% |
| Dec 31, 2025 | 4.16B | 98.67% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iRhythm Holdings | 3.87B |
| Integer Holdings | 3.06B |
| Haemonetics | 2.81B |
| Axogen | 2.20B |
| Establishment Labs Holdings | 2.09B |
| NovoCure | 2.07B |
| Neogen | 1.93B |
| UFP Technologies | 1.75B |